| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.11.2.254 |
| P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.11.2.254 |
| P698 | PubMed publication ID | 1847823 |
| P2093 | author name string | J. F. Martin | |
| R. M. Palmer | |||
| A. M. Gladwin | |||
| D. G. Hassall | |||
| P. M. Bath | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotaxis | Q658145 |
| Cardiology and cardiovascular medicine | Q96320350 | ||
| P304 | page(s) | 254-260 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro | |
| P478 | volume | 11 |
| Q40743830 | 1-O-hexyl-2,3,5-trimethylhydroquinone inhibits IkappaB phosphorylation and degradation-linked inducible nitric oxide synthase expression: beyond antioxidant function |
| Q43515037 | 17beta-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta |
| Q74259336 | A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function |
| Q41682201 | ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide |
| Q42368790 | Abolition of flow-dependent EDRF release before that evoked by agonists in hypercholesterolaemic rabbits |
| Q35599126 | Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release |
| Q45392433 | Activation of platelets upon contact with a vitamin E-coated/non-coated surface |
| Q72578113 | Acute normovolaemic anaemia prevents ethanol-induced gastric damage in rats through a blood flow related mechanism |
| Q35104616 | Adhesion Molecules, Catecholamines and Leucocyte Redistribution During and Following Exercise |
| Q35375871 | Age-related Notch-4 quiescence is associated with altered wall remodeling during vein graft adaptation |
| Q42707205 | Aminoguanidine-provoked leukocyte adherence to rat mesenteric venules: role of constitutive nitric oxide synthase inhibition |
| Q73689577 | Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts |
| Q28374195 | Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits |
| Q35822869 | Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit |
| Q46037040 | Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. |
| Q73292969 | Autocrine growth inhibition of IL-1 beta-treated cultured human aortic smooth muscle cells: possible role of nitric oxide |
| Q43070990 | Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release |
| Q33876371 | Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. |
| Q37315678 | Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis |
| Q78154242 | Beneficial effects of ginsenosides of stems and leaves on cardiac and coronary vascular functions after 12-hour rat heart preservation |
| Q40826491 | Bidirectional modulation of platelet and polymorphonuclear leukocyte activities |
| Q94363678 | Blood pressure management in acute stroke |
| Q46399987 | Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys |
| Q37575838 | Contractile protein expression is upregulated by reactive oxygen species in aorta of Goto-Kakizaki rat |
| Q74798319 | Control of risk factors in peripheral vascular disease. Management of hypertension |
| Q35563263 | Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension |
| Q40304100 | Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits |
| Q43748135 | Distinct involvement of NF-kappaB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal |
| Q37358590 | Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery |
| Q73181207 | Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells |
| Q41120249 | Effects of nitric oxide on cholesterol metabolism in macrophages |
| Q33815804 | Endothelial nitric oxide in humans in health and disease. |
| Q35877133 | Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells |
| Q50931838 | Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. |
| Q33771819 | Gender dimorphisms in progenitor and stem cell function in cardiovascular disease |
| Q40923166 | Gene transfer of nitric oxide synthase: effects on endothelial biology |
| Q43985272 | Hormonal influence on the release of endothelial nitric oxide: gender-related dimorphic sensitivity of rat aorta for noradrenaline |
| Q34627982 | Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro |
| Q48033517 | In vivo recruitment of neutrophils: consistent requirements for L-arginine and variable requirements for complement and adhesion molecules |
| Q24795387 | Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress |
| Q47822939 | Inducible nitric oxide synthase and atherosclerosis. |
| Q74341101 | Inhibition of endothelium-dependent arterial relaxation by oxidized phosphatidylcholine |
| Q41140097 | Inhibition of nitric oxide synthase by antisense techniques: investigations of the roles of NO produced by murine macrophages |
| Q74449503 | Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells |
| Q36330256 | Involvement of nitric oxide in the endothelium‐dependent relaxation induced by hydrogen peroxide in the rabbit aorta |
| Q34897476 | Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension? |
| Q40958378 | Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages |
| Q40872792 | Mechanisms of monocyte recruitment and accumulation |
| Q36868851 | Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. |
| Q41715190 | Molecular biology of atherosclerosis |
| Q40923118 | New approaches to the prevention of atherosclerosis |
| Q40552446 | Nitric oxide and endothelin in pathophysiological settings |
| Q77227013 | Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions |
| Q37556067 | Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart |
| Q35749970 | Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines |
| Q47775284 | Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline |
| Q33907931 | Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke |
| Q57689686 | Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke |
| Q36628207 | Nitric oxide function in atherosclerosis |
| Q32031553 | Nitric oxide modulates T-lymphocyte migration in Peyer's patches and villous submucosa of rat small intestine |
| Q37354925 | Nitric oxide production and perivascular nitration in brain after carbon monoxide poisoning in the rat. |
| Q48164897 | Nitric oxide synthetase activity in cerebral post-ischemic reperfusion and effects of L-N(G)-nitroarginine and 7-nitroindazole on the survival |
| Q40474853 | Nitric oxide: An overview |
| Q44582063 | Normalization by edaravone, a free radical scavenger, of irradiation-reduced endothelial nitric oxide synthase expression |
| Q41051281 | Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages |
| Q36998581 | PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis |
| Q37689190 | PPARgamma as a potential therapeutic target in pulmonary hypertension |
| Q71498767 | Pharmacotherapy of sepsis |
| Q34189108 | Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. |
| Q51381837 | Postprandial endothelial function, inflammation, and oxidative stress in obese children and adolescents. |
| Q24246809 | Prostacyclin and analogues for acute ischaemic stroke |
| Q33907692 | Prostacyclin and analogues for acute ischaemic stroke. |
| Q22254428 | Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis |
| Q37940831 | Reciprocal regulation of cellular nitric oxide formation by nitric oxide synthase and nitrite reductases. |
| Q33644486 | Role of NAD(P)H Oxidase in Superoxide Generation and Endothelial Dysfunction in Goto-Kakizaki (GK) Rats as a Model of Nonobese NIDDM |
| Q35046172 | Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro |
| Q41531468 | Role of endothelial dysfunction in coronary artery disease |
| Q43799883 | Role of nitric oxide on in vitro human eosinophil migration. |
| Q37045445 | Role of oxidative stress and nitric oxide in atherothrombosis |
| Q35833262 | Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. |
| Q37664560 | Serum nitric oxide levels in patients with coronary artery ectasia. |
| Q28236647 | Statin therapy and autoimmune disease: from protein prenylation to immunomodulation |
| Q48446149 | Tetramethylpyrazine analogue CXC195 ameliorates cerebral ischemia-reperfusion injury by regulating endothelial nitric oxide synthase phosphorylation via PI3K/Akt signaling |
| Q37283255 | The Contrary Impact Of Diabetes And Exercise On Endothelial Nitric Oxide Synthase Function |
| Q40920738 | The cardiac renin-angiotensin system: physiological relevance and pharmacological modulation. |
| Q70493623 | The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro |
| Q34658478 | The pathogenesis of diabetic retinopathy: old concepts and new questions |
| Q95805497 | The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells |
| Q40418229 | The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease |
| Q40810701 | The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy |
| Q30490373 | Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke |
| Q28246124 | Thrombin and vascular inflammation |
| Q41206412 | Vascular Endothelial Growth Factor Increases Endothelial Nitric Oxide Synthase Transcription In Huvec Cells |
| Q41669799 | Vein grafts: haemodynamic forces on the endothelium--a review |
| Q58795252 | Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS Phosphorylation |
Search more.